Nuevolution AB (publ) operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nuevolution AB (publ) with three other
pharmaceutical manufacturers in Europe:
ExpreS2ion Biotech Holding AB
sales of 8.87 million Swedish Kronor [US$904,003.92 ]
Erytech Pharma SA
(4.45 million Euro [US$4.91 million]
of which 100%
was Pharmacy), and
Oncoarendi Therapeutics SA
based in Poland
(3,000.00 Polish New Zlotys [US$771.21 ]
During the year ended December of 2018, sales at
Nuevolution AB (publ) were SEK 10.97 million (US$1.12 million).
increase of 13.7%
versus 2017, when the company's sales were SEK 9.65 million.
Despite this increase, sales are still
below the level achieved in 2016, when Nuevolution AB (publ)
reported sales of SEK 21.31 million.